233 related articles for article (PubMed ID: 28581205)
1. Testing radical prostatectomy in men with prostate cancer and oligometastases to the bone: a randomized controlled feasibility trial.
Sooriakumaran P
BJU Int; 2017 Nov; 120(5B):E8-E20. PubMed ID: 28581205
[TBL] [Abstract][Full Text] [Related]
2. NADiA ProsVue prostate-specific antigen slope, CAPRA-S, and prostate cancer--specific survival after radical prostatectomy.
Moul JW; Sarno MJ; McDermed JE; Triebell MT; Reynolds MA
Urology; 2014 Dec; 84(6):1427-32. PubMed ID: 25432832
[TBL] [Abstract][Full Text] [Related]
3. Larger maximum tumor diameter at radical prostatectomy is associated with increased biochemical failure, metastasis, and death from prostate cancer after salvage radiation for prostate cancer.
Johnson SB; Hamstra DA; Jackson WC; Zhou J; Foster B; Foster C; Song Y; Li D; Palapattu GS; Kunju L; Mehra R; Sandler H; Feng FY
Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):275-81. PubMed ID: 23886418
[TBL] [Abstract][Full Text] [Related]
4. Management of low risk and low PSA prostate cancer: long term results from the prostate cancer intervention versus observation trial.
Wilt TJ
Recent Results Cancer Res; 2014; 202():149-69. PubMed ID: 24531789
[TBL] [Abstract][Full Text] [Related]
5. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
Yossepowitch O; Eggener SE; Bianco FJ; Carver BS; Serio A; Scardino PT; Eastham JA
J Urol; 2007 Aug; 178(2):493-9; discussion 499. PubMed ID: 17561152
[TBL] [Abstract][Full Text] [Related]
6. Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients.
Spahn M; Joniau S; Gontero P; Fieuws S; Marchioro G; Tombal B; Kneitz B; Hsu CY; Van Der Eeckt K; Bader P; Frohneberg D; Tizzani A; Van Poppel H
Eur Urol; 2010 Jul; 58(1):1-7; discussion 10-1. PubMed ID: 20299147
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer-specific mortality after radical prostatectomy or external beam radiation therapy in men with 1 or more high-risk factors.
D'Amico AV; Chen MH; Catalona WJ; Sun L; Roehl KA; Moul JW
Cancer; 2007 Jul; 110(1):56-61. PubMed ID: 17530618
[TBL] [Abstract][Full Text] [Related]
8. Radical prostatectomy for high-risk prostate cancer: biochemical outcome.
Kawamorita N; Saito S; Ishidoya S; Ito A; Saito H; Kato M; Arai Y
Int J Urol; 2009 Sep; 16(9):733-8. PubMed ID: 19674167
[TBL] [Abstract][Full Text] [Related]
9. Positive margins after radical prostatectomy: implications for failure and role of adjuvant treatment.
Swanson GP; Lerner SP
Urol Oncol; 2013 Jul; 31(5):531-41. PubMed ID: 21775170
[TBL] [Abstract][Full Text] [Related]
10. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study.
Heidenreich A; Pfister D; Porres D
J Urol; 2015 Mar; 193(3):832-8. PubMed ID: 25254935
[TBL] [Abstract][Full Text] [Related]
11. Oncologic outcomes at 10 years following robotic radical prostatectomy.
Diaz M; Peabody JO; Kapoor V; Sammon J; Rogers CG; Stricker H; Lane Z; Gupta N; Bhandari M; Menon M
Eur Urol; 2015 Jun; 67(6):1168-1176. PubMed ID: 24996687
[TBL] [Abstract][Full Text] [Related]
12. Is preoperative serum prostate-specific antigen level significantly related to clinical recurrence after radical retropubic prostatectomy for localized prostate cancer?
Haukaas SA; Halvorsen OJ; Daehlin L; Hostmark J; Akslen LA
BJU Int; 2006 Jan; 97(1):51-5. PubMed ID: 16336328
[TBL] [Abstract][Full Text] [Related]
13. Seminal vesicle-sparing perineal radical prostatectomy improves early functional results in patients with low-risk prostate cancer.
Albers P; Schäfers S; Löhmer H; de Geeter P
BJU Int; 2007 Nov; 100(5):1050-4. PubMed ID: 17760889
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: results from a single institution series.
Tilki D; Schlenker B; John M; Buchner A; Stanislaus P; Gratzke C; Karl A; Tan GY; Ergün S; Tewari AK; Stief CG; Seitz M; Reich O
Urol Oncol; 2011; 29(5):508-14. PubMed ID: 19837614
[TBL] [Abstract][Full Text] [Related]
15. Undetectable prostate specific antigen in disseminated prostate cancer.
Beardo P; Fernández PL; Corral JM; Filella X; Alcover J
J Urol; 2001 Sep; 166(3):993. PubMed ID: 11490269
[No Abstract] [Full Text] [Related]
16. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
[TBL] [Abstract][Full Text] [Related]
17. Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factors.
Bloom KD; Richie JP; Schultz D; Renshaw A; Saegaert T; D'amico AV
Urology; 2004 Feb; 63(2):333-6. PubMed ID: 14972484
[TBL] [Abstract][Full Text] [Related]
18. Validation of pre- and postoperative nomograms used to predict the pathological stage and prostate cancer recurrence after radical prostatectomy: a multi-institutional study.
Hinev AI; Anakievski D; Kolev N; Marianovski V; Hadjiev V
J BUON; 2011; 16(2):316-22. PubMed ID: 21766504
[TBL] [Abstract][Full Text] [Related]
19. Prostate specific antigen at the initial diagnosis of metastasis to bone in patients after radical prostatectomy.
Loeb S; Makarov DV; Schaeffer EM; Humphreys EB; Walsh PC
J Urol; 2010 Jul; 184(1):157-61. PubMed ID: 20483148
[TBL] [Abstract][Full Text] [Related]
20. The association between pre-operative PSA and prostate cancer-specific mortality in patients with long-term follow-up after radical prostatectomy.
Lewinshtein D; Teng B; Valencia A; Gibbons R; Porter CR
Prostate; 2012 Jan; 72(1):24-9. PubMed ID: 21520159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
